GRI Bio, Inc.
GRI · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,823 | $956 | $1,968 | – |
| - Cash | $5,122 | $3,281 | $5,028 | – |
| + Debt | $96 | $108 | $119 | – |
| Enterprise Value | -$2,203 | -$2,217 | -$2,941 | – |
| Revenue | $0 | $22,538 | – | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$1 | $10,913 | – | -$1 |
| % Margin | – | 48.4% | – | – |
| EBITDA | -$2,896 | -$3,050 | – | -$1,952 |
| % Margin | – | -13.5% | – | – |
| Net Income | -$2,892 | -$3,046 | – | -$1,947 |
| % Margin | – | -13.5% | – | – |
| EPS Diluted | -1.31 | -5.8 | – | -7.86 |
| % Growth | 77.4% | – | – | – |
| Operating Cash Flow | -$3,166 | -$1,736 | -$1,999 | – |
| Capital Expenditures | $0 | -$396 | $0 | – |
| Free Cash Flow | -$3,166 | -$1,736 | -$1,999 | – |